AstraZeneca (AZN) to Join Nasdaq-100 Index
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
(Updated - February 10, 2022 5:02 PM EST)
Nasdaq today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.
For more information about the company, go to https://www.astrazeneca.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenland approves Critical Metals mining plan through 2050
- AstraZeneca closes $2 billion equity stake in Summit Therapeutics
- Citi Adjusts Catalyst Watch List
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Index Changes, Trader TalkRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
